As of 3:59pm ET
| -0.05 / -1.23%|
The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +225.00% increase from the last price of 4.00.
The current consensus among 1 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.